期刊文献+

HPLC法测定人血浆中的尼扎替丁浓度 被引量:1

Determination of concentration of nizatidine in human plasma using HPLC method
下载PDF
导出
摘要 目的:建立尼扎替丁血药浓度的HPLC测定方法。方法:血浆样品经甲醇直接沉淀蛋白进样。分析柱:Nucleosil100-5硅胶柱(4.6mm×250mm,5μm);流动相:乙腈:甲醇:水:氨水(1000:200:25:1.25,pH7.0);流速1.0mL/min;检测波长324nm。结果:该方法检测尼扎替丁的线性范围为15.625-2000ng/mL(r=0.9999),方法的日内和日间RSD<1.2%。结论:该方法简单、快速、准确、灵敏、经济,可用于尼扎替丁人体药动学研究。 Objective: To establish a HPLC method for determining the concentration of nizatidine in human plasma. Methods: The proteins were precipitated by adding methanol in the plasma samples, the supernatant was injected directly into the system. The analytical column was Nucleosil 100-5 (4. 6 mm×250 mm,5 μm),the mobile phase was acetonitrile: methanol:water:ammonia water (1000:200:25:1.25,pH 7.0),the flow rate was 1. 0 mL/min,the detection wavelength was 824 nm. Results: The linear range of nizatidine of the method was 15. 625-2 000 ng/mL (r=0. 999 9), the inter-and intra-day RSD were lower than 1. 2%. Conclusion: The method is simple, rapid, accurate, sensitive and economic. It can be used for studying pharmacokinetics of nizatidine in human body.
出处 《药学服务与研究》 CAS CSCD 2005年第1期64-65,共2页 Pharmaceutical Care and Research
关键词 尼扎替丁 色谱法 高压液相 血药浓度 nizatidine chromatography,high pressure liquid plasma concentration
  • 相关文献

参考文献3

  • 1Parente F, Bianchi-Porro G. Acid inhibitory characteristics of nizatidine in man: an overview [J]. Scand J Gastroenterol Suppl, 1994, 206: 3.
  • 2Tracqui A, Kintz P, Mangin P. Determination of nizatidine and two of its main metabolites in human serum using highperformance liquid chromatography[J]. J Chromatogr, 1990,529(2) :369.
  • 3Carlucci G. High-performance liquid chromatographic assay for nizatidine, a new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns[J]. J Chromatogr, 1990, 525(2):490.

同被引文献6

  • 1国家食品药品监督管理局.药物研究技术指导原则(2005年).北京:中国医药科技出版社,2006:28-37.
  • 2[1]Parente F,Bianchi Porto G.Acid inhibitory characteristics of nizatidine in man:an overview[J].Scand J Gastroenterol Suppl,1994,206:3-7.
  • 3[4]Tracqui A,Kintz P,Mangin P.Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography[J].J Chrornatogr,1990,529(2):369-376.
  • 4[5]Knadler MP,Bergstrom RF,Callaghan JT,et al.Abserption studies of the H2-bloeker nizatidine[J].Clin Pharmacol Ther,1987,42 (5):514-520.
  • 5[6]Sano H,Shinozaki Y,Seto Y,et al.Pharmacokinetic study in man and bioequivalenee of two different nizatidine formulations after oral administration[J].Arzneimittelforachung,1991,41(9):961-964.
  • 6[7]Schneck DW,Callaghan JT,Bergstrom RF,et al.Relationship between steady-state plasma nizatidine concentrations and inhibition of basal and stimulated gastric acid secretion[J].Clin Pharmacol Ther,1990,47(4):499-503.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部